germ tube test, corn meal agar, carbohydrate fermentation and assimilation test are performed but these procedures are labor intensive and take longer time for identification. To facilitate rapid identification, several chromogenic substrate containing culture media have been developed. The use of HiChrom agar has been reported to be valuable for the rapid and precise identification of albicans and non-albican species. [8] This study aims at identifying various Candida species using HiChrom agar in HIV-seropositive patients in different clinical variants of oral candidiasis as some Candida species are resistant to few antifungal agents. Identification of species becomes important to target the specific species with appropriate drug therapy.
Introduction
Oral Candidiasis is one of the most common fungal infections seen in association with human immunodeficiency virus (HIV) infection. [1] About 90% of patients are found to suffer from oropharyngeal or esophageal candidiasis in various stages of acquired immunodeficiency syndrome (AIDS).
[2] Candida albicans species is more often found in association with oral lesions. Over the past decade, there has been a significant increase in the number of reports of systemic and mucosal Candida infections with non-albicans candida species that cause a greater proportion of nosocomial infections. [3] Non-albicans Candida species such as C. glabrata, C. tropicalis, and C. krusei are occasionally isolated and are emerging important pathogens. [1, 4, 5] The presence of these species may have important implications for treatment, as some of these may have different susceptibilities to antifungal agents as well as differential expression of putative virulence factors. [1, 6] In addition, a new species -Candida dubliniesis linked with oral candidiasis in HIV infected and AIDS patients has recently been described. [7] To identify the species, various methods like The surface of the lesions were scraped using sterile cotton swabs. The swabs were then inoculated on Sabouraud's dextrose agar for primary culture. The colonies from Sabouraud's dextrose agar were inoculated on HiChrom agar (Hi Media) which was prepared following manufacturer's instructions and then incubated at 37°C for 24-48 hours. Based upon the color of the colonies the Candida species were identified. C. albicans colonies demonstrated light green color [ Figure 1 ], C. tropicalis steel blue color [ Figure 2 ], C. glabrata as pink color colonies, C. dubliniesis as dark green color [ Figure 3 ] and C. parapsilosis off white to cream color colonies [ Figure 4 ].
Results
The study included 30 HIV-seropositive patients. Out of the 30 patients, 20 were males and 10 were females.
A total of 66.6% (n = 20) of the cases had pseudomembraneous candidiasis (PC), 13.3% (n = 4) cases had chronic hyperplastic candidiasis (HPC), 3.3% (n = 1) case had erythematous candidiasis (EC), 10% (n = 3) cases had combination of PC and angular cheilitis (AC), 3.3% (n = 1) had AC and EC and remaining 3.3% (n = 1) had EC and PC.
The colors of the candidal species colonies on HiChrom agar are shown in Figures 1-4 . The present study reveals 48% of individuals have isolated with single Candida species either C. albicans or non-albicans and 52% were isolated with combination of Candida species [ Table 1 ]. A total of 46.6% (n = 14) cases showed combination of light green and purple color colonies of C. albicans and C. tropicalis, 16.6% (n = 5) cases showed light green colonies of C. albicans, 13.3% (n = 4) cases produced dark green colonies of C. dublienisis, 10%(n = 3) cases produced pink color colonies of C. glabrata, 6.6% (n = 2) produced off white colonies of C. parapsilosis, 3.3% (n = 1) produced deep blue colonies of C. tropicalis and 3.3% (n = 1) cases showed combination of off white and purple color colonies of C. parapsilosis and C. tropicalis. Distribution of clinical variants of oral candidiasis with candida species is shown in Table 1 , 23.3% (n = 7) had such as C. glabrata, C. tropicalis, and C. krusei are occasionally isolated and are emerging as important pathogens. [1, 4] The use of HiChrom agar has been reported to be valuable for the rapid and precise identification of Candida species. The present study reveals 48% of individuals have isolated a single Candida and 52% were isolated with combination of mixed candidal species [ Table 1 ]. C. albicans alone comprises of 16.6% cases and in combination with other species adds to 50% of the cases. A study done by VP Baradkar and S Kumar found 70% of 50 HIV infected patients were isolated with C. albicans. [4] We also found other non-albicans Candida species like C. parapsilopsis was 6.6% and C. tropicalis alone was 6.6% and along with other species was 56.5%. VP Baradkar found 15% non-albicans isolates in his study.
Total of 13.3% of C. dubliniensis was found in present study. In July 1995, C. dubliniensis which was a new species was found to be present in HIV infected individuals. Though there is a limited amount of data on the incidence of C. dubliniensis in HIV infected individuals, this organism has been recovered with increasing frequency from the oral cavities of a substantial number of HIV-infected and AIDS patients from a variety of countries throughout the world. Evidence indicates that C. dubliniensis is present as a commensal organism in many of these individuals but has been indirectly implicated as the causative agent of oral candidiasis in some. [10] Loreto et al., reviewed that the next commonest Candida species is C. dubliniesis in HIV-seropositive patients after C. albicans [11] Irogasi H et al., [12] has also mentioned that colonies of C. dubliniensis and C. albicans nearly appear same when inoculated on HiChrom agar media. A slight difference in color is found to differentiate them, hence it is necessary that other methods like tobacco agar, growth at 45°C or sugar tests should be used for confirmation.
The presence of more than one yeast species in clinical samples is not uncommon. Yamane and Saitoh as well as Samarnayake et al., have reported the association of yeast species with a relatively high frequency, ranging from 8% to 15.3% of the positive cultures, varying with the nature of the sample. Some Candida species such as C. lusitaniae are often resistant to amphotericin B; numerous isolates of C. tropicalis are resistant to 5-fluorocytosine; C. glabrata is less sensitive than other species to ketoconazole and fluconazole and C. krusei exhibits innate resistance to fluconazole. Thus, there has been increasing concern during the past few years that the extended use of ketoconazole or fluconazole as prophylactic or curative agents for mycoses may be associated with an increased incidence of C. glabrata and C. krusei infections. [13] The problems of "resistance" of these usually effective dosages and frequency of recurrences, which increase as the CD4 cells decline (reflecting failing immune competence), further complicate CD4 count 200-499 cells µl −1 and 3.33% (n = 1) had CD4 count ≥ 500 cells µl −1 . The distribution of candida species with CD4 count is presented in Table 2 . The most common species found were C. albicans in combination with C. tropicalis in cases with CD4 count ≤ 200 cells µl −1 .
Discussion
Generally, Candida exists in normal oral cavities without harm. [2] Oral candidiasis is a common oral complication of HIV infection that causes discomfort, often with declining immune competence, and is a challenge to manage because of its recurring nature. [9] Candidiasis presents itself in different clinical variants like PC, EC, HPC and AC. It is important to emphasize that PC and EC have been shown to be equally significant markers in the progression of HIV disease, independent of the CD4 count. [1] The role of Candida albicans as the main cause of oral candidiasis and its many variants is undisputed. Also, it is known that the host response plays a pivotal role in the pathogenesis. [7] Along with the Candida albicans species, non-albicans Candida species treatment. [9] Since these species are resistant to few drugs and may not respond to all, identification of these species is must to target the specific drug for treatment.
To conclude, the present study has identified various Candida species (albicans and non-albicans) in HIV-seropositive patients. Different Candida species respond to different antifungal agents and some non-C. albicans species are known to be resistant to few drugs and may not respond to all, hence identification of these species is must to target the specific drug for treatment.
